Adcock Ingram Holdings Ltd represents a strong set of values and a distinct corporate philosophy. The company prioritizes integrity, transparency, and ethical business practices, ensuring the highest standards in everything it does. Adcock Ingram Holdings Ltd values innovation, continuously striving to develop and deliver high-quality healthcare products for the benefit of its customers. With a customer-centric approach, the company aims to provide accessible and affordable healthcare solutions. Adcock Ingram Holdings Ltd strongly believes in fostering sustainable growth and contributing positively to the communities it operates in. Through its commitment to excellence, Adcock Ingram Holdings Ltd has become a trusted name in the pharmaceutical industry.

Adcock Ingram Holdings Ltd is primarily present in South Africa.

Adcock Ingram Holdings Ltd has achieved significant milestones throughout its history. Some noteworthy achievements include expanding its product portfolio to include a wide range of prescription and over-the-counter pharmaceuticals. The company has also successfully established itself as a key player in the South African healthcare industry, with a strong market presence and a reputation for delivering high-quality products. Adcock Ingram Holdings Ltd's dedication to research and development has led to the introduction of innovative healthcare solutions, further cementing its position as a leader in the market. Overall, the company's commitment to growth and innovation has contributed to its success and continues to drive its future prospects.

Adcock Ingram Holdings Ltd is a leading pharmaceutical company based in South Africa. Established in 1891, the company has a rich history in the healthcare industry. Adcock Ingram specializes in the manufacturing, marketing, and distribution of a wide range of pharmaceutical products, over-the-counter medicines, and personal care products. With a strong presence in both local and international markets, Adcock Ingram has become a trusted name in the pharmaceutical sector. The company has a proven track record of innovation, quality, and commitment to improving healthcare. Adcock Ingram Holdings Ltd continues to play a vital role in providing essential healthcare solutions to people worldwide.

The main competitors of Adcock Ingram Holdings Ltd in the market are Aspen Pharmacare Holdings Ltd and Cipla Medpro South Africa Ltd.

Adcock Ingram Holdings Ltd is primarily active in the pharmaceutical and healthcare industries.

The business model of Adcock Ingram Holdings Ltd is focused on the manufacturing, marketing, and distribution of a wide range of healthcare and pharmaceutical products. Adcock Ingram operates within two primary segments: Prescription and Over-the-Counter (OTC) medicines. Through its Prescription portfolio, the company produces innovative prescription drugs for various therapeutic areas, including cardiovascular, respiratory, and central nervous system disorders. Its OTC segment encompasses a diverse range of consumer healthcare products, such as vitamins, supplements, skincare, and pain relief remedies. Adcock Ingram consistently strives to strengthen its market presence, enhance product offerings, and provide accessible healthcare solutions to meet the evolving needs of its customers.

مُعامل القيمة السوقية إلى الأرباح لـ Adcock Ingram Holdings هو ١٬٢٤٨٫٥٣.

مُعامِل القيمة إلى المبيعات Adcock Ingram Holdings هو ١١٣٫٩١.

نقاط جودة AlleAktien لـ Adcock Ingram Holdings هي 6/10.

المتوقعة Adcock Ingram Holdings الإيرادات هي ٩٫٧٠ مليارات ZAR.

صافي الربح المتوقعة Adcock Ingram Holdings هو ٨٨٥٫٣١ مليون. ZAR.

Adcock Ingram Holdings Ltd is a pharmaceutical company that was founded in South Africa and is now one of the leading manufacturers and marketers of prescription and over-the-counter drugs, medical devices, and diagnostic tests in Africa. The company is divided into several business segments, including Prescription, Over-the-counter (OTC), Critical Care, Hospital, and Animal Health, each focusing on different market segments and customer needs. They offer prescription medications for various therapeutic areas, including cardiovascular diseases, diabetes, oncology, neurology, and psychiatry, as well as specialized products for women and children, generics, and biosimilars. In the OTC segment, they offer a wide range of over-the-counter drugs, including pain relievers, cold remedies, vitamins and minerals, herbal remedies, and skincare products. The Critical Care segment includes medications and medical devices for intensive care and emergency medicine, such as anesthetics, ventilators, infusion solutions, and blood products. In the Hospital segment, they provide products and services to hospitals and medical facilities, including antibiotics, anesthetics, diagnostics, and surgical instruments. The Animal Health segment offers veterinary drugs and products for farm and companion animals, including antibiotics, vaccines, and parasiticides. Adcock Ingram Holdings Ltd distributes its products through various channels, including pharmacies, hospitals, wholesalers, and veterinarians. The company also has subsidiaries in some African countries and exports some products to other countries. They emphasize research and development and have their own innovation center. Additionally, they collaborate closely with other research institutions and universities to develop new therapies and products. Adcock Ingram Holdings Ltd also emphasizes its responsibility to society and the environment and works on various initiatives to promote health, education, and environmental protection. Overall, their business model is focused on a wide range of products, customers, and markets. The company positions itself in the middle of the market, offering both prescription and over-the-counter products. Through research and development and close collaboration with other partners, they strive for continuous innovation. They also emphasize their social responsibility and commitment to sustainable development.

يوزع Adcock Ingram Holdings أرباحًا قدرها ٢٫١٣ ZAR من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Adcock Ingram Holdings في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـAdcock Ingram Holdings هو ZAE000123436.

الرمز المُختصر لـ Adcock Ingram Holdings هو AIP.JO.

خلال آخر 12 شهراً، دفعت Adcock Ingram Holdings توزيعات أرباح بقيمة ٢٫٥٠ ZAR . وهذا يعادل عائد توزيعات أرباح يقارب ٠٫٠٤ %. ومن المتوقع أن تدفع Adcock Ingram Holdings خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٢٫٧٣ ZAR.

نسبة توزيعات الأرباح الحالية لـ Adcock Ingram Holdings هي ٠٫٠٤ %.

Adcock Ingram Holdings يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أكتوبر, أبريل, أكتوبر, أكتوبر.

Adcock Ingram Holdings دفعت توزيعات الأرباح كل عام خلال الـ12 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٢٫٧٣ ZAR. وهذا يعادل عائد توزيعات أرباح قدره ٠٫٠٤ %.

Adcock Ingram Holdings يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫٠٨ ZAR من Adcock Ingram Holdings المُعلن عنها في ٢٣‏/٩‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٠‏/٩‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٢٣‏/٩‏/٢٠٢٤.

في العام 2023، وزعت Adcock Ingram Holdings ٢٫١٣ ZAR كأرباح أسهم.

يتم توزيع أرباح Adcock Ingram Holdings بالعملة ZAR.